Related Experiment Video
Updated: Feb 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Adult Congenital Interventions in Heart Failure
Hussam S Suradi1, Ziyad M Hijazi2
1Interventional Cardiology, Structural Heart & Valve Center, St. Mary Medical Center, 1500 South Lake Park Avenue, Suite 100, Hobart, IN 46342, USA; Department of Cardiology, Community Hospital, Munster, IN 46321, USA; Rush Center for Structural Heart Disease, Rush University Medical Center, Chicago, IL 60612, USA.
Insights
Congenital heart disease (CHD) affects about 1% of newborns. Transcatheter interventions are increasingly vital for treating adults with CHD, improving outcomes and preventing complications.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Congenital heart disease (CHD) is the most common birth defect.
- Improved survival rates mean more CHD patients are reaching adulthood.
- Adults with CHD face risks of heart failure and premature death if not managed properly.
Purpose of the Study:
- To discuss the role of transcatheter interventions in managing adult congenital heart disease (ACHD).
- To highlight percutaneous therapies as a primary treatment for adults with uncorrected or palliated CHD.
Main Methods:
- Review of current literature on transcatheter interventions for adult CHD.
- Discussion of the application of percutaneous therapies in ACHD management.
Main Results:
- Transcatheter interventions are effective for various forms of CHD in adults.
- Percutaneous approaches offer a primary treatment option for many ACHD cases.
Conclusions:
- Transcatheter interventions are crucial in the modern management of adults with CHD.
- Appropriate management, including percutaneous therapies, can mitigate long-term complications in ACHD patients.
Abstract:
Congenital heart disease (CHD) is the most common birth defect, occurring in approximately 0.8% to 1.0% of neonates. Advances in medical and surgical therapies for children with CHD have resulted in a growing population of patients reaching adulthood, with survival rates exceeding 85%. Many of these patients, especially if managed inappropriately, face the prospect of future complications including heart failure and premature death. For adults with uncorrected or previously palliated CHD, percutaneous therapies have become the primary treatment for many forms of CHD. In this article, we discuss the role of transcatheter interventions in the treatment of adults with CHD.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation

